• Markets
  • icon
  • Companies
BIO · ASX

Biome Australia Ltd (ASX:BIO)

AU$0.14

 0.0 (0.0%)
ASX:Live
01/12/2023 04:10:47 PM
HALO Ords GROWTH AUS Big Candle All-Consensus All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

BIO Overview

BIO Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About BIO

Website

N/A

Telephone

N/A

Address

Description

Biome Australia Ltd. engages in the research, development, manufacture, and distribution of evidence-based products linking the gut and human health. It offers live biotherapeutics products and complementary medicines under the Activated Probiotic brand. The company was founded by Blair Vega Norfolk on July 6, 2018 and is headquartered in Collingwood, Australia.

BIO Price Chart

Key Stats

Market Cap

AU$24.28M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.06 - 0.15

Trade Value (12mth)

AU$4,563.00

1 week

8%

1 month

12.5%

YTD

90.14%

1 year

73.08%

All time high

0.15

Key Fundamentals

EPS 3 yr Growth

-3.200%

EBITDA Margin

-42.30%

Operating Cashflow

-$3m

Free Cash Flow Return

-61.30%

ROIC

-54.00%

Interest Coverage

-97.70

Quick Ratio

1.30

Other Data

Shares on Issue (Fully Dilluted)

202m

HALO Sector

Next Company Report Date

23-Jul-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BIO Announcements

Latest Announcements

Date Announcements

31 March 23

Biome signs corporate advisory mandate with Canary Capital

×

Biome signs corporate advisory mandate with Canary Capital

31 March 23

Proposed issue of securities - BIO

×

Proposed issue of securities - BIO

31 March 23

Notification regarding unquoted securities - BIO

×

Notification regarding unquoted securities - BIO

31 July 23

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

31 July 23

Trading Update

×

Trading Update

31 August 22

Application for quotation of securities - BIO

×

Application for quotation of securities - BIO

31 August 22

Delivery of Activated Probiotics to 370 Priceline Pharmacies

×

Delivery of Activated Probiotics to 370 Priceline Pharmacies

30 September 22

Annual Report

×

Annual Report

30 September 22

Appendix 4G & Corporate Governance Statement

×

Appendix 4G & Corporate Governance Statement

30 November 23

Application for quotation of securities - BIO

×

Application for quotation of securities - BIO

30 May 22

Biome signs distribution agreement with Priceline Pharmacy

×

Biome signs distribution agreement with Priceline Pharmacy

30 June 22

Application for quotation of securities - BIO

×

Application for quotation of securities - BIO

30 January 23

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

30 August 22

Release of Restricted Securities from Escrow

×

Release of Restricted Securities from Escrow

29 November 22

Chair and Managing Director Annual General Meeting Address

×

Chair and Managing Director Annual General Meeting Address

29 November 22

Results of Annual General Meeting

×

Results of Annual General Meeting

29 November 22

Constitution

×

Constitution

29 March 22

Application for quotation of securities - BIO

×

Application for quotation of securities - BIO

29 June 22

Amended Live Biotherapeutic-study on subthreshold depression

×

Amended Live Biotherapeutic-study on subthreshold depression

29 July 22

Application for quotation of securities - BIO

×

Application for quotation of securities - BIO

29 August 22

Preliminary Final Report

×

Preliminary Final Report

28 September 23

Annual Report

×

Annual Report

28 September 23

Appendix 4G & Corporate Governance Statement

×

Appendix 4G & Corporate Governance Statement

28 November 23

Revenue Update

×

Revenue Update

28 November 23

Results of Annual General Meeting

×

Results of Annual General Meeting

28 November 23

Constitution

×

Constitution

28 March 22

Application for quotation of securities - BIO

×

Application for quotation of securities - BIO

28 June 23

Biome secures $1.2 million revolving debt facility

×

Biome secures $1.2 million revolving debt facility

BIO Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.03 -0.02 -0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.03 -0.02 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -70.3 15.6 32.6 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.02 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.02 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 8.2 -54.5 21.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A -23.7 -27.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock N/A 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 0.03 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.03 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 67.6 312.9 -45.6 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 200 200 201 Lock Lock Lock
Basic m Lock Lock Lock Lock 200 200 201 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 2 4 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 167.7 77.8 75.5 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 7 7 7 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 1 2 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 363.6 114.9 76.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 46.2 55.9 56.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 54 44 44 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -5 -4 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -109.3 23.5 26.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -233.6 -100.5 -42.3 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -6 -4 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -112.0 23.5 22.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -238.3 -102.5 -45.3 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -6 -5 -3 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -5 -5 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -70.2 15.6 32.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -232.1 -110.1 -42.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -2 -3 -3 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 3 8 1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -2 -4 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 27.5 -44.2 -9.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.1 -0.9 -0.5 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 1 6 2 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 2 8 8 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -1 -5 -1 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 2 4 Lock Lock Lock
Equity $m Lock Lock Lock Lock 2 7 4 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 2 7 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 14.4 319.5 -34.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -215.3 -55.0 -40.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -340.5 -69.6 -85.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -354.7 -97.7 -55.9 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -349.1 -106.3 -54.0 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -155.3 -80.1 -61.3 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -79.9 -126.3 -97.7 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.1 1.2 0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -35.1 -77.9 -31.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.8 5.7 2.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.6 4.7 1.3 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 26.5 72.6 33.4 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -279.9 -253.2 -117.1 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.3 5.4 6.5 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.3 1.6 1.5 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.5 0.7 1.9 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 26.7 27.3 31.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.9 0.5 1.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.9 0.5 1.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -239.8 -115.6 -47.1 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -222.4 -57.7 -45.1 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -215.3 -55.0 -40.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.6 1.3 2.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -340.5 -69.6 -85.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A -69.6 -85.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 286.0 232.9 248.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 85.7 67.9 56.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 371.7 300.7 304.4 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 120.9 151.8 126.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 250.8 149.0 177.8 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BIO Shortsell

Frequently Asked Questions

The current share price of Biome Australia Ltd (BIO:ASX) is AU$0.14.
The 52-week high share price for Biome Australia Ltd (BIO:ASX) is AU$0.15.
The 52-week low share price for Biome Australia Ltd (BIO:ASX)? is AU$0.06.
Biome Australia Ltd (BIO:ASX) does not pay a dividend.
Biome Australia Ltd (BIO:ASX) does not pay a dividend.
Biome Australia Ltd (BIO:ASX) has a franking level of 0%.
Biome Australia Ltd (BIO:ASX) is classified in the Healthcare.
The current P/E ratio for Biome Australia Ltd (BIO:ASX) is .